News Focus
News Focus
icon url

midastouch017

07/21/20 10:51 AM

#37094 RE: jaime9_2000 #37092

The company confirmed it expects to have enough cash for 3 years
Hopefully, this means no further dilution.



The question is: If enough cash for 3 years, what was
the urgent need for this sale agreement?

Entry into a Material Definitive Agreement.

On July 16, 2020, Pluristem Therapeutics Inc.,
or the registrant, entered into an Open Market Sale AgreementSM,
or the Sale Agreement, with Jefferies LLC, or
Jefferies, as agent, pursuant to which the registrant
may issue and sell shares of its common stock having an
aggregate offering price of up to $75 million from time
to time through Jefferies.

#msg-157002213